Patents by Inventor Chenlu LI

Chenlu LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12219371
    Abstract: A method and system for networking of spliced building blocks, and the spliced building blocks applicable to wireless networking are provided.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: February 4, 2025
    Assignee: SHANGHAI BLOKS TECHNOLOGY GROUP CO., LTD.
    Inventors: Jialiang Zhao, Chao Gao, Ye Xiao, Shanjun Deng, Song Liu, Chang Liu, Shanjun Li, Chenlu Liu
  • Patent number: 10759812
    Abstract: The present invention relates to a thienopyrimidine derivative and use thereof in medicine, and also to a pharmaceutical composition containing the compound. The compound or pharmaceutical composition is used for inhibiting acetyl-CoA carboxylase (ACC). The present invention also relates to a method of preparing such compound and pharmaceutical composition, as well as their use in the treatment or prevention of diseases regulated by acetyl-CoA carboxylase in mammals, especially in humans.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: September 1, 2020
    Assignee: Sunshine Lake Pharma Co., Ltd.
    Inventors: Wanjun Tang, Xinye Yang, Zheng Gu, Chenlu Li, Zongyuan Zhang, Zhifu Wan, Xiaojun Wang, Yingjun Zhang
  • Publication number: 20190352311
    Abstract: The present invention relates to a thienopyrimidine derivative and use thereof in medicine, and also to a pharmaceutical composition containing the compound. The compound or pharmaceutical composition is used for inhibiting acetyl-CoA carboxylase (ACC). The present invention also relates to a method of preparing such compound and pharmaceutical composition, as well as their use in the treatment or prevention of diseases regulated by acetyl-CoA carboxylase in mammals, especially in humans.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 21, 2019
    Applicants: SUNSHINE LAKE PHARMA CO., LTD., NORTH & SOUTH BROTHER PHARMACY INVESTMENT COMPANY LIMITED
    Inventors: Wanjun TANG, Xinye YANG, Zheng GU, Chenlu LI, Zongyuan ZHANG, Zhifu WAN, Xiaojun WANG, Yingjun ZHANG
  • Patent number: D1063076
    Type: Grant
    Filed: May 5, 2023
    Date of Patent: February 18, 2025
    Assignee: SHENZHEN SHOKZ CO., LTD.
    Inventors: Sunjie Huang, Lei Zhong, Chaowu Li, Qianwen Nie, Chenlu Lou, Qingyu Zeng, Fengyun Liao